| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.6M | +37.7% |
| Cost of Revenue | $5.8M | +33.3% |
| Gross Profit | $2.8M | +47.9% |
| R&D Expense | $18K | -75.6% |
| SG&A Expense | $4.6M | +26.2% |
| Operating Income | -$1.9M | +0.1% |
| Interest Expense | $42K | +97.4% |
| Pre-tax Income | -$1.9M | -19.2% |
| Net Income | -$1.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $484K | -24.7% |
| Accounts Receivable | $112K | -9.3% |
| Inventory | $2.4M | +27.8% |
| Current Assets | $3.3M | +10.1% |
| Total Assets | $5.7M | +21.2% |
| Current Liabilities | $1.8M | +28.4% |
| Long-term Debt | $210K | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$678K | +11.8% |
| Capital Expenditures | $11K | -53.4% |
| Investing Cash Flow | -$62K | -112.0% |
| Financing Cash Flow | $582K | +5.8% |
| Free Cash Flow | -$689K | +13.1% |
| -19.2% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Total Liabilities |
| $3.1M |
| +53.6% |
| Stockholders' Equity | $2.5M | -4.0% |